Financial Times Publishes Special Report on “Combating Tuberculosis” and Features Guest Columns

24 Mar 2010
by Working Group

FT Combating Tuberculosis Special Report
FT Combating Tuberculosis Special Report

The Financial Times created a special report on “Combating Tuberculosis” that was published for World TB Day on March 24, 2010.

Articles in the special report include:

  • Complacency is one of the greatest risks
  • Treatment is too complex and too slow
  • Mobile X-Rays can reach farther
  • The global burden of TB
  • Untreated HIV exacts a high price
  • Drive is on to replace venerable 90-year-old vaccine

You can download a .pdf of the report by clicking here.

The FT also ran Guest Columns:

  • Jorge Sampaio, the UN Secretary-General’s Special Envoy to Stop TB, writes on how the private sector has a crucial role to play.
  • Luis Figo, Stop TB Ambassador and football icon, writes on how, like football, the fight against B requires teamwork and endurance.
  • Craig David, the Stop TB Partnership’s newly appointed Goodwill Ambassador against Tuberculosis, writes about Voices Against Stigma. You can also read more about Craig David’s new role with Stop TB by clicking here.
More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...